Marco Investment Management LLC Takes $233,000 Position in Balchem Co. (NASDAQ:BCPC)

Marco Investment Management LLC purchased a new position in shares of Balchem Co. (NASDAQ:BCPC) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 1,325 shares of the basic materials company’s stock, valued at approximately $233,000.

Several other large investors have also recently added to or reduced their stakes in the company. Algert Global LLC raised its stake in shares of Balchem by 88.7% during the 3rd quarter. Algert Global LLC now owns 17,781 shares of the basic materials company’s stock worth $3,129,000 after buying an additional 8,360 shares in the last quarter. Nicolet Advisory Services LLC grew its holdings in Balchem by 6.6% during the third quarter. Nicolet Advisory Services LLC now owns 3,662 shares of the basic materials company’s stock worth $626,000 after acquiring an additional 228 shares during the period. Citigroup Inc. lifted its holdings in Balchem by 61.1% in the third quarter. Citigroup Inc. now owns 43,178 shares of the basic materials company’s stock valued at $7,599,000 after acquiring an additional 16,378 shares during the period. Charles Schwab Investment Management Inc. boosted its position in shares of Balchem by 2.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 361,970 shares of the basic materials company’s stock worth $63,707,000 after purchasing an additional 7,562 shares in the last quarter. Finally, Intech Investment Management LLC grew its stake in shares of Balchem by 55.6% during the 3rd quarter. Intech Investment Management LLC now owns 8,611 shares of the basic materials company’s stock worth $1,516,000 after purchasing an additional 3,077 shares during the period. 87.91% of the stock is owned by hedge funds and other institutional investors.

Balchem Trading Up 1.2 %

Balchem stock opened at $182.44 on Monday. The stock has a market cap of $5.93 billion, a PE ratio of 49.04, a P/E/G ratio of 5.39 and a beta of 0.65. The company has a current ratio of 2.98, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21. The stock has a 50-day moving average price of $173.84 and a 200 day moving average price of $166.71. Balchem Co. has a 52 week low of $120.81 and a 52 week high of $186.03.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. StockNews.com upgraded shares of Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th. HC Wainwright boosted their price target on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday, November 4th.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.